The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Contract Manufacturing
Contract Manufacturing
Agilent’s Biovectra drives GLP-1 growth with ‘healthy’ contribution from the CDMO
Overall, the company’s specialty CDMO business grew in the low-double digits during the first quarter of fiscal 2026, with expectations of mid-teens growth this year.
Feb. 26, 2026
Contract Manufacturing
Charles River inks agreement to divest CDMO, cell solutions businesses to GI Partners
Feb. 25, 2026
Contract Manufacturing
IDT Biologika looks to double its sales by 2028 in post-acquisition growth phase
Feb. 24, 2026
Contract Manufacturing
Siegfried says customer uncertainty weighs on drug substances sales growth in 2026
Feb. 23, 2026
Contract Manufacturing
Piramal builds global drug product, ADC capacity amid supply chain volatility
Feb. 19, 2026
Contract Manufacturing
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Feb. 18, 2026
Contract Manufacturing
Lifecore Biomedical benefits from pharma onshoring, secures tech transfers
Feb. 13, 2026
Contract Manufacturing
Fujifilm opens expanded UK biomanufacturing site
Feb. 11, 2026
Contract Manufacturing
Recipharm CEO says 2025 was ‘not an easy year’ for the CDMO
Feb. 10, 2026
Looking for Something?
Load More Content